Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 1 19Phase 3 14Phase 1/2 10Phase 2/3 3Phase NA 2Phase EARLY_PHASE1 2

Status

Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Carcinoma, Non-Small-Cell Lung 13Triple Negative Breast Neoplasms 7Breast Neoplasms 6Lung Neoplasms 5Ovarian Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Endometrial Neoplasms 3Carcinoma, Ovarian Epithelial 3Neoplasms 2Medulloblastoma 2Fallopian Tube Neoplasms 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Urethral Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thymoma 1Thymic epithelial tumor 1Thrombocythemia, Essential 1Stage IIIB or IV Non-Small Cell Lung Cancer 1Squamous NSCLC 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Retinoblastoma 1Recurrence 1Primary Myelofibrosis 1Primary Malignant Neoplasm of Ovary 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Megestrol Acetate 4Letrozole 4Paclitaxel 3Medroxyprogesterone Acetate 3Carboplatin 3Gonadotropin-Releasing Hormone 2Cisplatin 2spartalizumab 1sintilimab 1ricin A-GnRH conjugate 1olaparib 1niraparib 1navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1durvalumab 1atezolizumab 1Tablets 1Progestins 1Progesterone 1Observation 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Drug Therapy 1Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Endometrial Neoplasms × Carboplatin × Clear all
NCT05255653 2026-05-15

RAINBO

Leiden University Medical Center

Phase 2/3 Recruiting
1,615 enrolled
Gynecologic

Endometrial Neoplasms

NCT06321068 2025-08-14

BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer

Bio-Thera Solutions

Phase 2/3 Terminated
5 enrolled
Gynecologic

Endometrial Neoplasms

NCT05489848 2022-08-05

Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation

Fudan University

Phase 2/3 Not yet recruiting
294 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡